DCT

1:26-cv-01533

VitalGo Systems Ltd v. Kreg Therap LLC

Key Events
Complaint
complaint Intelligence

I. Executive Summary and Procedural Information

  • Parties & Counsel:
  • Case Identification: 1:26-cv-01533, E.D. Va., 06/03/2026
  • Venue Allegations: Plaintiff alleges venue is proper because Defendant has committed acts of infringement in the district and maintains a regular and established place of business, specifically a physical distribution and service center in Henrico, Virginia.
  • Core Dispute: Plaintiff alleges that Defendant's "Catalyst Bed" product line infringes a patent related to a multi-position hospital bed featuring a processor-controlled movable foot support designed to prevent patient sliding during verticalization.
  • Technical Context: The technology pertains to advanced patient-handling medical devices, specifically hospital beds capable of safely transitioning a patient from a supine (lying) position to an upright, near-standing position to facilitate early mobility.
  • Key Procedural History: The complaint alleges a prior business relationship where Defendant was a distributor for Plaintiff's patented "Total Lift Bed." Following the termination of this relationship, Defendant allegedly developed its competing product. Plaintiff also alleges that Defendant had actual knowledge of the patent-in-suit at least as of March 25, 2014, based on Defendant having cited the patent in an Information Disclosure Statement (IDS) during the prosecution of its own, separate patent application.

Case Timeline

Date Event
2005-05-17 Earliest Priority Date for '984 Patent
2005-01-01 VitalGo founded and began patent development efforts
2008-01-01 VitalGo demonstrated working prototypes of its Total Lift Bed
2009-01-01 VitalGo commercially introduced the first-generation Total Lift Bed
2009-12-01 VitalGo engaged Kreg Therapeutics as a distributor
2011-05-01 VitalGo's distributorship agreement with Kreg ended
2013-10-29 U.S. Patent No. 8,566,984 Issued
2014-03-25 Kreg allegedly cited '984 patent in an IDS for its own patent prosecution
2014-04-18 Kreg filed a provisional patent application for its own bed technology
2016-01-01 Kreg launched the accused Catalyst Bed
2026-06-03 Complaint Filed

II. Technology and Patent(s)-in-Suit Analysis

  • Patent Identification: U.S. Patent No. 8,566,984 (Multi-Position Support Apparatus Featuring a Movable Foot Support), issued October 29, 2013.

The Invention Explained

  • Problem Addressed: The patent background describes the difficulties elderly, sick, or mobility-impaired patients face when moving between lying, sitting, and standing positions on conventional beds '984 Patent, col. 3:31-38 A specific problem noted is the risk of a user sliding down the bed or becoming unstable when the bed is tilted from a horizontal to a vertical orientation Compl. ¶49 '984 Patent, col. 1:40-45
  • The Patented Solution: The invention is a multi-position bed that incorporates a processor to intelligently control a movable foot support. The processor is programmed to first cause the foot support to move toward the head of the bed ("headward movement") to securely engage the bottom of the user's feet while the bed is still in a resting (e.g., lying or sitting) position '984 Patent, col. 1:57-61 The processor then maintains this engagement as the entire bed frame tilts towards a vertical position, thereby using the foot support as a stable platform to prevent the patient's body from sliding down the mattress '984 Patent, col. 1:61-64
  • Technical Importance: This automated, two-step stabilization process was designed to enhance patient safety and independence, facilitate early mobility therapy, and reduce the risk of injury to both patients and caregivers during transitions Compl. ¶¶51-52

Key Claims at a Glance

  • The complaint asserts infringement of at least independent claim 1 '984 Patent, Claim 1 Compl. ¶55
  • The essential elements of independent claim 1 are:
    • An apparatus for supporting a user comprising a "tiltable frame assembly tiltably mounted on a base".
    • A "body support" carried by the tiltable frame.
    • A "foot support" extending across the foot end of the body support.
    • "Drive means" for moving the tiltable frame between resting and vertical positions.
    • A "processor programmed to cause headward movement of the foot support", engaging the user's feet when the frame is in a "resting position".
    • The processor is further programmed "to maintain said feet-engaging position" while the frame moves to the vertical position, thereby preventing the user's body from sliding.
  • The complaint appears to reserve the right to assert additional claims by stating infringement of "at least claim 1" Compl. ¶55

III. The Accused Instrumentality

Product Identification

  • Defendant Kreg's "Catalyst Bed," including but not limited to the "Catalyst Critical Recovery Bed" Compl. ¶¶38, 42

Functionality and Market Context

  • The Catalyst Bed is described as a medical bed that provides "Verticalization Therapy," moving a patient from a resting position to a vertical one Compl. ¶39 The complaint alleges the bed includes a tiltable frame, a movable foot support, and a processor that controls the footboard's movement Compl. ¶¶38, 43 The product is marketed to hospitals for early patient mobility and rehabilitation, the same field pioneered by Plaintiff's Total Lift Bed Compl. ¶39 An image from Kreg's marketing materials shows an on-screen instruction for the footboard: "Footboard must be in the 'zero' position or bed will not tilt," which suggests a processor-controlled sequence of operations (Compl. ¶38).

IV. Analysis of Infringement Allegations

  • '984 Patent Infringement Allegations
Claim Element (from Independent Claim 1) Alleged Infringing Functionality Complaint Citation Patent Citation
Apparatus for supporting a user in a resting position and/or a vertical exiting position, comprising: a tiltable frame assembly tiltably mounted on a base; The accused Catalyst Bed is an apparatus with a tiltable frame assembly mounted on a base for supporting a user. Ex. H, p. 2 col. 4:1-3
a body support carried by said tiltable frame assembly... The Catalyst Bed includes a body support with a head end and a foot end, carried by the tiltable frame. Ex. H, p. 2 col. 4:3-5
a foot support extending transversely across the foot end of the body support; The Catalyst Bed includes a foot support that extends across the foot end of its body support. Ex. H, p. 2 col. 4:5-7
and drive means for driving said tiltable frame assembly to said resting position and to said substantially vertical exiting position; The Catalyst Bed includes drive means to move the tiltable frame between resting and vertical positions. Ex. H, p. 3 col. 4:15-18
characterized in that said apparatus further comprises a processor programmed to cause headward movement of the foot support, thereby engaging the bottom surface of the user's feet, when the tiltable frame assembly is in said resting position The complaint alleges the Catalyst Bed has a processor that controls the foot support. A control screen image shows buttons for "MOVE FOOTBOARD IN" and "MOVE FOOTBOARD OUT," which allegedly causes headward movement to engage the user's feet. Ex. H, p. 3 col. 1:57-61
and to maintain said feet-engaging position while the tiltable frame assembly is moving towards said vertical position, to thereby prevent sliding of the user's body when the tiltable frame assembly is tilted. The complaint provides images from a Kreg training video allegedly showing the Catalyst Bed maintaining the foot support's engagement with the patient's feet as the bed is tilted upward, thereby preventing the patient from sliding. Ex. H, p. 4 col. 1:61-64
  • Identified Points of Contention:
    • Scope Questions: A central question will be whether the accused product's operation falls within the scope of the "processor programmed to" limitation. This will involve determining if the Catalyst Bed's software executes the specific, sequential logic required by the claim: (1) moving the footboard to engage the feet while in a resting position, and (2) maintaining that engagement while tilting. The defense may argue that its product's control logic differs in a meaningful way from this claimed sequence.
    • Technical Questions: What evidence demonstrates that the accused product's processor is specifically "programmed" to perform the claimed function? The complaint relies on user-facing materials like control screens and training videos Compl. Ex. H, pp. 3-4 The actual operational logic, potentially found in the device's source code, will be a key piece of evidence to substantiate or refute the allegations.

V. Key Claim Terms for Construction

  • The Term: "processor programmed to cause headward movement of the foot support... when the tiltable frame assembly is in said resting position"

    • Context and Importance: This term from the "characterized in that" clause defines the inventive concept. The infringement case hinges on whether the Catalyst Bed's processor is programmed to perform this specific action under this specific condition. Practitioners may focus on this term because it sets up a conditional, sequential operation that distinguishes the invention from prior art.
    • Intrinsic Evidence for Interpretation:
      • Evidence for a Broader Interpretation: The specification describes the processor's function in general terms, stating it is "programmed to control the drive means... for performing the foregoing operations" '984 Patent, col. 4:15-18 This could support an argument that any processor-controlled movement of the foot support toward the user's head before or at the start of tilting meets the limitation.
      • Evidence for a Narrower Interpretation: The claim language explicitly requires the "headward movement" to occur "when the tiltable frame assembly is in said resting position." The abstract reinforces this sequence '984 Patent, abstract A defendant might argue that "resting position" means only a specific, fully horizontal or seated state, and that if their product initiates footboard movement at any other time (e.g., simultaneously with the start of tilting), it does not infringe.
  • The Term: "to maintain said feet-engaging position"

    • Context and Importance: This term is critical because it defines the second step of the processor's required programming-stabilizing the patient during the tilting motion. Whether the accused product's static footboard placement qualifies as "maintaining" the position will be a point of contention.
    • Intrinsic Evidence for Interpretation:
      • Evidence for a Broader Interpretation: "Maintain" could be interpreted broadly to mean simply keeping the foot support in the established feet-engaging position relative to the patient and bed frame, without requiring active adjustments. The purpose is "to thereby prevent sliding" '984 Patent, Claim 1, and a fixed footboard achieves this.
      • Evidence for a Narrower Interpretation: A defendant could argue that "maintain" implies an active, continuous process of holding the position against opposing forces, rather than a passive, one-time placement. However, the specification does not appear to describe any such active feedback loop, weakening this potential argument. The primary description is of moving the support to engage the feet and then tilting '984 Patent, col. 4:9-15

VI. Other Allegations

  • Indirect Infringement: The complaint alleges inducement of infringement, stating Kreg "knowingly" encourages customers to use the Catalyst Bed in an infringing manner by providing product manuals, user guides, and promotional materials that instruct on its operation Compl. ¶55 Contributory infringement is also pled, alleging the accused products are especially made for infringing use and are not staple articles of commerce Compl. ¶55
  • Willful Infringement: The complaint makes a detailed allegation of willfulness. It is based on both the parties' prior distributor relationship, which allegedly gave Kreg access to and knowledge of the technology, and a specific allegation of pre-suit knowledge Compl. ¶¶34, 58 The complaint asserts that Kreg had actual knowledge of the '984 patent no later than March 25, 2014, when it submitted the patent in an Information Disclosure Statement (IDS) to the USPTO during the prosecution of its own patent application Compl. ¶56

VII. Analyst's Conclusion: Key Questions for the Case

  1. A core issue will be one of operational sequence: Does the accused Catalyst Bed's software perform the specific, two-part function required by Claim 1-first, moving the foot support to engage the patient's feet while the bed is in a resting position, and second, maintaining that engagement while the bed tilts? The case will likely turn on evidence of the product's actual programmed logic, not just its resulting physical movements.
  2. A second key question will be one of intent: Given the allegation that Defendant cited the '984 patent in its own patent prosecution years before the lawsuit, a central issue for willfulness and potential enhanced damages will be whether Defendant developed and sold the Catalyst Bed with knowledge of, and in deliberate disregard of, Plaintiff's patent rights.
  3. The dispute may also raise a question of claim construction: The court's interpretation of what constitutes a "resting position" and what actions satisfy the requirement "to maintain" the feet-engaging position will be fundamental in defining the scope of infringement.